QA: TG Therapeutics INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001001316_2015_TG_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001001316, TG Therapeutics INC

  xvar xval
0 AssetsCurrent 85,215,029
1 IntangibleAssetsNetIncludingGoodwill 799,391
2 PropertyPlantAndEquipmentNet 20,357
3 remainder_Assets 712,113
4 LiabilitiesCurrent 5,121,196
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,523,810
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,787,126
9 ResearchAndDevelopmentExpense 40,086,347
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 92,196
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 86,746,890
1 Liabilities 6,645,006
2 Expenses 55,873,473
3 Revenues 0
4 StockholdersEquity 80,101,884
5 NetIncome -55,781,277
6 ComprehensiveNetIncome -55,781,277
7 BaseVar 74,678,782
8 EconomicCapitalRatiobeforeLimitedLiability 2.54
9 EconomicCapitalRatio 3.39

Edgar->Model Mapping

Feature Distribution

Change over Time